X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs LUPIN LTD - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES LUPIN LTD PIRAMAL ENTERPRISES/
LUPIN LTD
 
P/E (TTM) x 38.9 23.5 165.7% View Chart
P/BV x 3.2 3.2 101.7% View Chart
Dividend Yield % 0.8 0.8 95.5%  

Financials

 PIRAMAL ENTERPRISES   LUPIN LTD
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-17
LUPIN LTD
Mar-17
PIRAMAL ENTERPRISES/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2,0951,750 119.7%   
Low Rs1,0251,384 74.1%   
Sales per share (Unadj.) Rs492.8387.4 127.2%  
Earnings per share (Unadj.) Rs72.656.6 128.1%  
Cash flow per share (Unadj.) Rs94.776.8 123.2%  
Dividends per share (Unadj.) Rs21.007.50 280.0%  
Dividend yield (eoy) %1.30.5 281.2%  
Book value per share (Unadj.) Rs862.5298.9 288.5%  
Shares outstanding (eoy) m172.56451.58 38.2%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x3.24.0 78.3%   
Avg P/E ratio x21.527.7 77.7%  
P/CF ratio (eoy) x16.520.4 80.8%  
Price / Book Value ratio x1.85.2 34.5%  
Dividend payout %28.913.2 218.6%   
Avg Mkt Cap Rs m269,194707,513 38.0%   
No. of employees `0004.016.8 23.9%   
Total wages/salary Rs m17,93928,495 63.0%   
Avg. sales/employee Rs Th21,190.310,418.3 203.4%   
Avg. wages/employee Rs Th4,470.11,697.0 263.4%   
Avg. net profit/employee Rs Th3,120.01,523.0 204.9%   
INCOME DATA
Net Sales Rs m85,037174,943 48.6%  
Other income Rs m2,3381,065 219.5%   
Total revenues Rs m87,374176,008 49.6%   
Gross profit Rs m34,99144,931 77.9%  
Depreciation Rs m3,8179,122 41.8%   
Interest Rs m20,3101,525 1,331.5%   
Profit before tax Rs m13,20235,349 37.3%   
Minority Interest Rs m1,699-72 -2,369.6%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m-1000-   
Tax Rs m2,2819,785 23.3%   
Profit after tax Rs m12,52025,575 49.0%  
Gross profit margin %41.125.7 160.2%  
Effective tax rate %17.327.7 62.4%   
Net profit margin %14.714.6 100.7%  
BALANCE SHEET DATA
Current assets Rs m87,590119,542 73.3%   
Current liabilities Rs m185,57861,206 303.2%   
Net working cap to sales %-115.233.3 -345.6%  
Current ratio x0.52.0 24.2%  
Inventory Days Days3176 40.8%  
Debtors Days Days4890 52.9%  
Net fixed assets Rs m108,523131,660 82.4%   
Share capital Rs m345903 38.2%   
"Free" reserves Rs m148,481134,073 110.7%   
Net worth Rs m148,826134,976 110.3%   
Long term debt Rs m144,95756,478 256.7%   
Total assets Rs m482,394266,073 181.3%  
Interest coverage x1.724.2 6.8%   
Debt to equity ratio x1.00.4 232.8%  
Sales to assets ratio x0.20.7 26.8%   
Return on assets %6.810.2 66.8%  
Return on equity %8.418.9 44.4%  
Return on capital %12.019.3 62.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,00181,885 18.3%   
Fx outflow Rs m5,15021,506 23.9%   
Net fx Rs m9,85160,378 16.3%   
CASH FLOW
From Operations Rs m-100,39341,148 -244.0%  
From Investments Rs m-24,202-25,287 95.7%  
From Financial Activity Rs m135,7054,332 3,132.8%  
Net Cashflow Rs m11,11020,193 55.0%  

Share Holding

Indian Promoters % 52.9 46.6 113.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 4.0 11.3 35.4%  
FIIs % 26.6 31.9 83.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 10.1 163.4%  
Shareholders   93,274 98,259 94.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   SHASUN PHARMA  WYETH LTD  ASTRAZENECA PHARMA  SUVEN LIFE  CIPLA  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jan 24, 2018 02:35 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS